Suchergebnisse

145 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: 抗新生物性, antineoplastisch, antineoplastic

• 2016, Shoji H, Motegi M, Osawa K, Okonogi N, Okazaki A, Andou Y, Asao T, Kuwano H, Takahashi T, Ogoshi K
  Output-limiting symptoms induced by radiofrequency hyperthermia. Are they predictable? [tech./dosim.]
  Int J Hyperthermia 32 (2): 199-203
• 2015, Xu L, Guo W, Liu Y, Zhang X, Yu J, Wu W, Zhao T
  [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells] [fremdsprachig]
  Sheng Wu Gong Cheng Xue Bao 31 (9): 1363-1374
• 2015, Sampson JH
  Alternating Electric Fields for the Treatment of Glioblastoma [Kommentar]
  JAMA 314 (23): 2511-2513
• 2015, Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z
  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial [med. Anw.]
  JAMA 314 (23): 2535-2543
• 2015, Tofani S
  [Details] Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment [Review]
  Curr Top Med Chem 15 (6): 572-578
• 2015, Zong C, Ji Y, He Q, Zhu S, Qin F, Tong J, Cao Y
  [Details] Adaptive response in mice exposed to 900 MHz radiofrequency fields: Bleomycin-induced DNA and oxidative damage/repair [med./bio.]
  Int J Radiat Biol 91 (3): 270-276
• 2015, Zhou J, Li X, Liao Y, Feng W, Fu C, Guo X
  Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats [med./bio.]
  Endocrine 49 (1): 258-266
• 2014, Wocik-Piotrowicz K, Kaszuba-Zwoinska J, Rokita E, Thor P, Chrobik P, Nieckarz Z, Michalski J
  [Details] Influence of static and alternating magnetic fields on U937 cell viability [med./bio.]
  Folia Med Cracov 54 (4): 21-33
• 2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
  Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. Anw.]
  Cancer Med 3 (3): 592-602
• 2014, Wen J, Jiang S, Chen Z, Zhao W, Yi Y, Yang R, Chen B
  Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field [med./bio.]
  Int J Nanomedicine 9: 2043-2050
• 2014, Mahna A, Firoozabadi SM, Shankayi Z
  The Effect of ELF Magnetic Field on Tumor Growth after Electrochemotherapy [med. Anw.]
  J Membr Biol 247 (1): 9-15
• 2014, Gellrich D, Becker S, Strieth S
  Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel [med./bio.]
  Cancer Lett 343 (1): 107-114
• 2014, Salwa SP, Bourke MG, Forde PF, O'Shaughnessy M, O'Sullivan ST, Kelly EJ, Soden DM, Clover AJ
  Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management [med. Anw.]
  J Plast Reconstr Aesthet Surg 67 (3): 403-406
• 2013, Butowski N, Wong ET, Mehta MP, Wilson LK
  A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields [Grundlagen]
  Semin Oncol 40 (6): S2-S4
• 2013, Pless M, Droege C, von Moos R, Salzberg M, Betticher D
  A Phase I/II Trial of Tumor Treating Fields (TTFields) Therapy in Combination with Pemetrexed for Advanced Non-Small Cell Lung Cancer [med. Anw.]
  Lung Cancer 81 (3): 445-450
• 2013, Kolmatsui NB, Levitskii EF, Golosova OE, Pyzhova IB
  [The application of UHF therapy for the prevention of complications of specific antiblastoma therapy in the patients presenting with III-IV stage lung cancer] [fremdsprachig]
  Vopr Kurortol Fizioter Lech Fiz Kult (2): 4-7
• 2013, El-Bialy NS, Rageh MM
  Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma [med./bio.]
  Biomed Res Int: 189352
• 2013, Trillo MA, Martinez MA, Cid MA, Ubeda A
  [Details] Retinoic acid inhibits the cytoproliferative response to weak 50Hz magnetic fields in neuroblastoma cells [med./bio.]
  Oncol Rep 29 (3): 885-894
• 2013, Shankayi Z, Firoozabadi SM, Mansurian MG
  The effect of pulsed magnetic field on the molecular uptake and medium conductivity of leukemia cell [med./bio.]
  Cell Biochem Biophys 65 (2): 211-216
• 2012, Cid MA, Ubeda A, Hernandez-Bule ML, Martinez MA, Trillo MA
  [Details] Antagonistic effects of a 50 Hz magnetic field and melatonin in the proliferation and differentiation of hepatocarcinoma cells [med./bio.]
  Cell Physiol Biochem 30 (6): 1502-1516
• 2012, Fonkem E, Wong ET
  NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (8): 895-899
• 2012, Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH
  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality [med. Anw.]
  Eur J Cancer 48 (14): 2192-2202
• 2012, Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y
  The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells [med./bio.]
  PLoS One 7 (9): e46102
• 2012, Miyakoshi Y, Kajihara C, Shimizu H, Yanagisawa H
  [Details] Tempol suppresses micronuclei formation in astrocytes of newborn rats exposed to 50-Hz, 10-mT electromagnetic fields under bleomycin administration [med./bio.]
  Mutat Res Genet Toxicol Environ Mutagen 747 (1): 138-141
• 2012, Raffa V, Riggio C, Smith MW, Jordan KC, Cao W, Cuschieri A
  BNNT-mediated irreversible electroporation: its potential on cancer cells [med./bio.]
  Technol Cancer Res Treat 11 (5): 459-465